Preterm intraamniotic infection and inflammation: Search for protein biomarkers via proteomics approach

Authors

  • Niu Jin Tan Clinical Genetics Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
  • Amilia Afzan Mohd Jamil Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
  • Norhafizah Mohtarrudin Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
  • Sunhare Raksha Clinical Genetics Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
  • Karuppiah Thilakavathy Clinical Genetics Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.

DOI:

https://doi.org/10.54987/jobimb.v2i2.148

Abstract

Preterm delivery (PTD) is commonly caused by intraamniotic infection and inflammation (IAI) and is one of the leading causes of maternal and neonatal morbidity or mortality worldwide. IAI in pregnant women with high risk of PTD can be classified according to the membrane status; preterm labour with intact membranes (PLIM) and preterm pre-labour rupture of membranes (PPROM). At present, the treatment for PTD-associated IAI is principally based on antibiotic
therapy. However, this therapy is found to be only beneficial to PPROM. Several IAI related protein biomarkers have been identified. Unfortunately, most of the studies that discovered the biomarkers focused on categorising term delivery and PTD-associated IAI, and to a lesser extent on the membrane status. Therefore, identifying a panel of highly sensitive and specific protein biomarkers that are able to discriminate IAI pregnant women at high risk of PTD with PLIM from PPROM are urgently needed to improve the treatment benefits. Over the past decade, proteomics technologies have been applied widely in identifying PTD-associated IAI biomarkers. This review brings together information on PTD-associated IAI protein biomarkers and touches on the combination of multivariable biomarkers to develop a more sensitive and specific biomarkers to discriminate PTD-associated IAI with PLIM from PPROM. Proteomics technologies and its workflow on protein biomarkers discovery are also included in this review.

References

Burd I, Balakrishnan B and Kannan S. Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol. 2012;67(4):287-94. doi: 10.1111/j.1600-0897.2012.01110.x.

Ganu RS, Ma J and Aagaard KM. The role of microbial communities in parturition: is there evidence of association with preterm birth and perinatal morbidity and mortality? Am J Perinat. 2013;30(8):613-24. doi: 10.1055/s-0032-1329693.

Hyman RW, Fukushima M, Jiang H, Fung E, Rand L, Johnson B et al. Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci. 2014;21(1):32-40.doi: 10.1177/1933719113488838.

Goldenberg RL, Culhane JF, Iams JD and Romero R. Epidemiology and causes of preterm birth. The lancet. 2008;371(9606):75-84. doi:10.1016/S0140-6736(08)60074-4.

Muglia L and Katz MD. The enigma of spontaneous preterm birth.-New-Engl-J-Med.-2010;362(6):529-35.doi:10.1056/NEJMra0904308.

Ananth CV and Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern-fetal Neo M. 2006; 19(12):773-82.

Steer P. The epidemiology of preterm labour. BJOG-Int J Obstet Gy. 2005;112(s1):1-3.

Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB et al. Born Too Soon: The global epidemiology of 15 million preterm births. Reprod Health. 2013; 10(Suppl 1):S2.

Plunkett J and Muglia LJ. Genetic contributions to preterm birth: implications from epidemiological and genetic association studies.-Ann-Med.-2008;40(3):167-95. doi:10.1080/07853890701806181.

Gravett MG, Rubens CE, Nunes TM et al. Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth. 2010; 10(Suppl 1):S2. doi:10.1186/1471-2393-10-S1-S2.

Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J et al. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. BJOG-Int J Obstet Gy. 2006;113(5):528-35.

Patel RR, Steer P, Doyle P, Little MP and Elliott P. Does gestation vary by ethnic group? A London-based study of over 122 000 pregnancies with spontaneous onset of labour. Int J Epidemiol. 2004;33(1):107-13. doi:10.1093/ije/dyg238.

Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gyn Scan. 2008;87(6):590—600. doi: 10.1080/00016340802005126.

Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S et al. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. The Lancet. 2013; 381(9862):223-34. doi:10.1016/S0140-6736(12)61856-X.

Linnan MJ, Mascola L, Lou XD, Goulet V, May S, Salminen C et al. Epidemic listeriosis associated with Mexican-style cheese. New Engl J Med. 1988;319(13):823-8.

Topalovski M, Samuel YS and Boonpasat Y. Listeriosis of the placenta: clinicopathologic study of seven cases. Am J Obstet Gynecol. 1993;169(3):616-20.

Romero R, Espinoza J, Gonccalves LF, Kusanovic JP, Friel LA and Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 2006;11(5):317-26.

Fahey JO. Clinical management of intra-amniotic infection and Chorioamnionitis: A Review of the Literature. J Midwifery Wom Heal.2008;53(3):227-35.doi: 10.1016/j.jmwh.2008.01.001.

Gilstrap LC, Leveno KJ and Cunningham FG. Spontaneous pneumomediastinum in pregnancy. Tex Med. 1979; 75(11): 39–40.

Simpson KR. Sepsis during pregnancy. JOGNN. 1995; 24(6):550-6. doi:10.1111/j.1552-6909.1995.tb02393.x.

Edwards LE, Barrada MI, Hamann AA and Hakanson EY. Gonorrhea in pregnancy. Am J Obstet Gynecol. 1978; 132(6):637-41.

Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA and Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 1986; 256(14):1899-903.

Epstein F, Goldenberg RL, Hauth JC and Andrews WW. Intrauterine infection and preterm delivery. New Engl J Med. 2000;342(20):1500-7. doi:10.1056/NEJM200005183422007.

Garite TJ and Freeman RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol. 1982; 59(5):539-45.

Romero R, Roslansky P, Oyarzun E, Wan M, Emamian M, Novitsky TJ et al. Labor and infection: II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol. 1988; 158(5):1044-9.

Miller Jr JM, Pupkin MJ and Hill GB. Bacterial colonization of amniotic fluid from intact fetal membranes. Am J Obstet Gynecol.1980; 136(6): 796-804.

Wahbeh CJ, Hill GB, Eden RD and Gall SA. Intra-amniotic bacterial colonization in premature labor. Am J Obstet Gynecol. 1984; 148(6):739-43.

Stys SJ, Clarke KE, Clewell WH and Meschia G. Hormonal Effects on Cervical Compliance in Sheep. In: Naftolin F, Stubblefield P, editors. Dilatation of the Uterine Cervix. New York: Raven Press; 1980. P. 147–56.

Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y et al. Infection and labor: VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol. 1992; 167(4):1086-91.

Naim A, Haberman S, Burgess T, Navizedeh N and Minkoff H. Changes in cervical length and the risk of preterm labor. Am J Obstet Gynecol. 2002; 186(5):887-9.

Han YW, Shen T, Chung P, Buhimschi IA and Buhimschi CS. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol. 2009; 47(1):38-47. doi:10.1128/JCM.01206-08.

Fredricks DN, Fiedler TL and Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. New-Engl-J-Med.-2005;353(18):1899-911.doi:10.1056/NEJ-Moa043802.

Apantaku O and Mulik V. Maternal intra-partum fever. J Obstet Gynaecol. 2007; 27(1):12-5.

Subramaniam A, Abramovici A, Andrews WW and Tita AT. Antimicrobials for preterm birth prevention: an overview. Infectious diseases in obstetrics and gynecology. 2012; (2012). doi.org/10.1155/2012/157159.

Kenyon S, Boulvain M and Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Db Syst Rev. 2010;(2).

Mercer B. Antibiotics in the management of PROM and preterm labor. Obstet Gyn Clin N Am. 2012:39(1):65–76. doi:10.1016/j.ogc.2011.12.007.

Ovalle A, Romero R, Gomez R, Angelica Martinez M, Nien JK, Ferrand P et al. Antibiotic administration to patients with preterm labor and intact membranes: Is there a beneficial effect in patients with endocervical inflammation? J Matern-Fetal Neo M. 2006; 19(8):453-64.

Flenady V, Hawley G, Stock OM, Kenyon S and Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Db Syst Rev. 2013;12.

Sung HJ and Cho JY. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep. 2008;41(9):615-25.

Sung MH, Salvatore L, De Lorenzi R, Indrawan A, Pasparakis M, Hager GL et al. Sustained oscillations of NF–kappaB produce distinct genome scanning and gene expression profiles. PloS one. 2009; 4(9):e7163. doi:10.1371/journal.pone.0007163.

Stroncek DF, Burns C, Martin BM, Rossi L, Marincola FM and Panelli MC. Advancing cancer biotherapy with proteomics. J Immunother. 2005; 28(3):183-92.

Jacobsson B, Holst RM, Andersson B and Hagberg H. Monocyte chemotactic protein-2 and-3 in amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra-amniotic inflammation and preterm delivery. Acta Obstet Gyn Scan. 2005; 84(6):566-71.

Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2001;185(5):1130-6.

Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Wennerholm U et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet Gyn Scan. 2003;82(2):120-8.

Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many-causes.-Science.-2014;-345(6198):760-5. doi:10.1126/science.1251816.

Buhimschi IA, Zhao G, Funai EF, Harris N, Sasson IE, Bernstein IM et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol. 2008;199(5):551.e1-16. doi: 10.1016/j.ajog.2008.07.006.

Charlton JR, Norwood VF, Kiley SC, Gurka MJ and Chevalier RL. Evolution of the urinary proteome during human renal development and maturation: variations with gestational and postnatal age. Pediatr Res. 2012; 72(2):179-85.

Woo SJ, Park KH, Lee SY, Ahn SJ, Ahn J, Park KH et al. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. Invest Ophth Vis Sci. 2013; 54(5):3434-9.

Kuhrt K, Seed P, Smout E, Hezelgrave N and Shennan A. The development and validation of a new tool to predict spontaneous preterm birth in high risk women using quantitative fetal fibronectin and cervical length. 2013; 120(s1):14-15.

Guest PC, Gottschalk MG and Bahn S. Proteomics: improving biomarker translation to modern medicine. Genome Med. 2013; 5(2):17. doi:10.1186/gm421.

Myers JE, Tuytten R, Thomas G, Laroy W, Kas K, Vanpoucke G et al. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia. Hypertension. 2013; 61(6):1281-8. doi:10.1161/HYPERTENSIONAHA.113.01168.

Sirard MA, Dufort I, Coenen K, Tremblay K, Massicotte L and Robert C. The use of genomics and proteomics to understand oocyte and early embryo functions in farm animals. Reproduction Supplement. 2002;61:117-29.

Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995; 172(3):960-70.

Watts HD, Krohn MA, Hillier SL and Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol. 1992;79(3):351-7.

Goncalves L, Chaiworapongsa T and Romero R. Intrauterine infection and prematurity. Ment Retard Dev D R. 2002;8(1):3-13.

Buhimschi I, Christner R and Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG-International J Obstet Gy. 2005;112(2):173-81.

Buhimschi CS, Buhimschi IA, Abdel-Razeq S, Rosenberg VA, Thung SF, Zhao G et al. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res. 2007;61(3):318-24.

Weiner CP, Lee KY, Buhimschi CS, Christner R and Buhimschi IA. Proteomic biomarkers that predict the clinical success of rescue cerclage. Am J Obstet Gynecol. 2005; 192(3):710-8.

Aaltonen R, Heikkinen J, Vahlberg T, Jensen JS and Alanen A. Local inflammatory response in choriodecidua induced by Ureaplasma urealyticum. BJOG-International J Obstet Gy. 2007;1 14(11):1432-5.

Romero R and Mazor M. Infection and preterm labor. Clin Obstet Gynecol. 1988; 31(3):553-84.

Hsu CD, Meaddough E, Aversa K and Copel JA. The role of amniotic fluid L-selectin, GRO-alpha, and interleukin-8 in the pathogenesis of intraamniotic infection. Am J Obstet Gynecol. 1998; 178(3):428-32.

Goncalves L, Chaiworapongsa T and Romero R. Intrauterine infection and prematurity. Ment Retard Dev D R. 2002;8(1):3-13.

Lamont RF. The role of infection in preterm labour and birth. Hosp Med. 2003;64(11):644-7.

Palacio M, Cobo T, Bosch J, Filella X, Navarro-Sastre A, Ribes A et al. Cervical length and gestational age at admission as predictors of intra-amniotic inflammation in preterm labor with intact membranes. Ultrasound Obst Gyn. 2009; 34(4):441-7. doi: 10.1002/uog.6437.

Romero R, Brody DT, Oyarzun E, Mazor M, King Wu Y, Hobbins JC et al. Infection and labor: III. Interleukin-1: A signal for the onset of parturition. Am J Obstet Gynecol. 1989; 160(5):1117-23

.

Cassell G, Andrew W, Hauth J, Cutter G, Hamrick W, Baldus K and Waites K. Isolation of microorganisms from the chorioamnion is twice that from amniotic fluid at cesarean delivery in women with intact membranes. Am J Obstet Gynecol.-1993;168(1):424.-doi:10.1016/s00029378(12)911023.

Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R and Cassell GH. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol. 1995; 173(2):606-612.

Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12(4): 262-79.

Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M and Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179(1):194-202.

Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000; 183(5):1124--1129.

Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Nikolaitchouk N et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gyn Scan. 2003; 82(5):423-31.

Taylor BD, Holzman CB, Fichorova RN, Tian Y, Jones NM, Fu W et al. Inflammation biomarkers in vaginal fluid and preterm delivery.-Hum-Reprod.-2013;-28(4):942-52.doi: 10.1093/humrep/det019.

Hillier SL, Witkin SS, Krohn MA, D Heather Watts, Kiviat NB and Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 1993;81(6):941-8.

Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177(1):19-26.

Wei SQ, Fraser W and Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol. 2010; 116(2 Part 1):393-401. doi: 10.1097/AOG.0b013e3181e6dbc0.

Hitti J, Riley DE, Krohn MA, Hillier SL, Agnew KJ, Krieger JN et al. Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis. 1997;24(6):1228-32.

Conde-Agudelo A, Papageorghiou A, Kennedy SH and Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG-International J Obstet Gy. 2011;118(9):1042-54.

Jacobsson B. Infectious and inflammatory mechanisms in preterm birth and cerebral palsy. Eur J Obstet Gyn R B. 2004; 115(2):159-60.

Hofmann P, Sprenger H, Kaufmann A, Bender A, Hasse C, Nain M et al. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukocyte Biol. 1997; 61(4):408-14.

Yoshida M, Sagawa N, Itoh H, Yura S, Takemura M, Wada Y et al. Prostaglandin F(2alpha), cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells. Mol Hum Reprod. 2002; 8(7):681-7.

Olson DM. The role of prostaglandins in the initiation of parturition. Best Pract Res Cl Ob. 2003;17(5):717-30.

Vadillo-Ortega F and Estrada-Guti'errez G. Role of matrix metalloproteinases in preterm labour. BJOG-International J Obstet Gy. 2005;112(s1):19-22.

Angus SR, Segel SY, Hsu CD, Locksmith GJ, Clark P, Sammel MD et al. Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic-infection.-Am-J-Obstet-Gynecol. 2001; 185(5): 1232-8.

Maymon E, Romero R, Chaiworapongsa T, Berman S, Conoscenti G, Gomez R et al. Amniotic fluid matrix metalloproteinase--8 in preterm labor with intact membranes. Am J Obstet Gynecol. 2001; 185(5):1149-55.

Nien JK, Yoon BH, Espinoza J, Kusanovic J, Erez O, Soto E et al. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol. 2006; 195(4):1025-30.

Noguchi T, Sado T, Naruse K, Shigetomi H, Onogi A, Haruta S et al. Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth. Mediat Inflamm. 2010; (2010) 1–10.doi.org/10.1155/2010/490406.

Pettker C, Buhimschi I, Magloire LK, Sfakianaki AK, Hamar BD and Buhimschi CS. Value of placental microbial evaluation in diagnosing intra-amniotic infection. Obstet Gynecol. 2007; 109(3):739-49.

Romero R, Espinoza J, Hassan S, Gotsch F, Kusanovic JP, Avila C et al. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med. 2008; 36(5):388-98. doi: 10.1515/JPM.2008.076.

Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cerebr Blood F Met. 2007; 28(5):927-38.

Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007; 204(12):2913-23.

Ivanov S, Dragoi A, Wang X, Dallacosta C, Louten J, Musco G et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood. 2007; 110(6):1970-81.

Luan ZG, Zhang H, Yang PT, Ma XC, Zhang C and Guo RX. HMGB1 activates nuclear factor-kB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells. Immunobiology. 2010; 215(12):956-62. doi: 10.1016/j.imbio.2009.11.001.

Qin YH, Dai SM, Tang GS, Zhang J, Ren D, Wang ZW et al. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol.-2009;-183(10):6244-50. doi: 10.4049/jimmunol.0900390.

Qiu J, Xu J, Zheng Y, Wei Y, Zhu X, Lo EH et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke. 2010;41(9):2077-82. doi: 10.1161/STROKEAHA.110.590463.

Romero R, Chaiworapongsa T, Alpay Savasan Z, Xu Y, Hussein Y, Dong Z et al. Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern-Fetal Neo M. 2011;24(12):1444-55. doi: 10.3109/14767058.2011.591460.

Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B et al. Understanding RAGE, the receptor for advanced glycation end products. J Moll Med. 2005;83(11):876-86.

Sennstrom MB, Ekman G, Westergren-Thorsson G, Malmstrom A, Bystrom B, Endresen U et al. Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod. 2000;6(4):375-81.

Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA et al. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003; 9(1):41-5.

Kagan BL, Selsted ME, Ganz T and Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. P Natl Acad Sci USA. 1990;87(1):210-4.

Ganz T and Lehrer RI. Antimicrobial peptides of vertebrates. Curr Opin Immunol. 1998;10(1):41-4.

Heizmann CW, Fritz G and Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002; 7(1):1356-68.

Striz I and Trebichavsky I. Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004; 53(3):245-53.

Nair RR, Khanna A and Singh K. Role of inflammatory proteins S100A8 and S100A9 in pathophysiology of recurrent early pregnancy loss. Placenta. 2013; 34(9):824-7. doi: 10.1016/j.placenta.2013.06.307.

Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004; 292(4):462-9.

Lee SE, Han BD, Park IS, Romero R and Yoon BH. Evidence supporting proteolytic cleavage of insulin-like growth factor binding protein-1 (IGFBP-1) protein in amniotic fluid. J Perinat Med. 2008; 36(4):316-23.

Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res. 2005;4(6):2236-42.

Espinoza J, Chaiworapongsa T, Romero R, Edwin S, Rathnasabapathy C, Gomez R et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern-Fetal Neo M. 2003; 13(1):2-21.

Buhimschi I, Christner R and Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG-International J Obstet Gy. 2005; 112(2):173-81.

Romero R, Kadar N, Miranda J, Korzeniewski SJ, Schwartz AG, Chaemsaithong P et al. The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6. J Matern-Fetal Neo M. 2014; 27(8):757-69. doi: 10.3109/14767058.2013.844123.

Athayde N, Romero R, Gomez R, Maymon E, Pacora P, Mazor M et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern-Fetal Neo M. 1999; 8(5):213-9.

Goldenberg RL, Mercer BM, Meis PL, Copper RL, Das A, McNellis D et al. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol. 1996; 87(5, Part 1):643-8.

Balu RB, Savitz DA, Ananth CV, Hartmann KE, Miller WC, Thorp JM et al. Bacterial vaginosis, vaginal fluid neutrophil defensins, and preterm birth. Obstet Gynecol. 2003; 101(5, Part 1):862-8.

Hitti J, Lapidus JA, Lu X, Reddy AP, Jacob T, Dasari S et al. Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid. Am J Obstet Gynecol. 2010; 203(1):32-e1-8. doi: 10.1016/j.ajog.2010.03.037.

Holst RM, Laurini R, Jacobsson B, Samuelsson E, Savman K, Doverhag C et al. Expression of cytokines and chemokines in cervical and amniotic fluid: relationship to histological chorioamnionitis. J Matern-Fetal Neo M. 2007; 20(12):885-93.

Romero R, Espinoza J, Rogers WT, Moser A, Kae nien J, Pedro kusanovic J et al. Proteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profiling. J Matern-Fetal Neo M. 2008; 21(6):367-88. doi: 10.1080/14767050802045848.

Liong S, Di Quinzio MK, Heng YJ, Fleming G, Permezel M, Rice GE et al. Proteomic analysis of human cervicovaginal fluid collected before preterm premature rupture of the fetal membranes. Reproduction. 2013; 145(2):137-47. doi: 10.1530/REP-12-0264.

Quinzio MKD, Georgiou HM, Holdsworth–Carson SJ, Ayhan M, Heng YJ, Walker SP et al. Proteomic Analysis of Human Cervico- Vaginal Fluid Displays Differential Protein Expression in Association with Labor Onset at Term. J Proteome Res. 2008; 7(5):1916-21. doi: 10.1021/pr7006413.

Heng YJ, Di Quinzio MK, Permezel M, Ayhan M, Rice GE and Georgiou HM. Temporal proteomic analysis of human cervicovaginal fluid with impending term labor. J Proteome Res. 2010; 9(3):1344-50. doi: 10.1021/pr900892f.

Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. The EMBO J. 1998; 17(9):2596-606.

Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T et al. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem Bioph Res Co. 2000;274(1):177-82.

Telfer JF, Thomson AJ, Cameron IT, Greer IA and Norman JE. Expression of superoxide dismutase and xanthine oxidase in myometrium, fetal membranes and placenta during normal human pregnancy and parturition. Hum Reprod. 1997; 12(10):2306-12.

Buhimschi IA, Kramer WB, Buhimschi CS, Thompson LP and Weiner CP. Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol. 2000; 182(2):458-64.

Pereira L, Reddy AP, Alexander AL, Lu X, Lapidus JA, Gravett MG et al. Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor. Am J Obstet Gynecol. 2010; 202(6):555-e1-10. doi: 10.1016/j.ajog.2010.02.048.

Esplin MS, Merrell K, Goldenberg R, Lai Y, Iams JD, Mercer B et al. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2011; 204(5):391-e1-8. doi: 10.1016/j.ajog.2010.09.021.

Lee JW. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics. Bioanalysis. 2009; 1(8):1461-74. doi: 10.4155/bio.09.130.

Kalinina J, Peng J, Ritchie JC and Van Meir EG. Proteomics of gliomas: initial biomarker discovery and evolution of technology. Neuro-oncology. 2011; 13 (9):926-42. doi: 10.1093/neuonc/nor078.

Brewis IA and Brennan P. Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol. 2010; 80:1-44. doi: 10.1016/B978-0-12-381264-3.00001-1.

Srivastava S and Srivastava RG. Proteomics in the forefront of cancer biomarker discovery. J Proteome Res. 2005; 4(4):1098-103. doi:10.1021/pr050016u.

Rabilloud T, Valette C and Lawrence JJ. Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis. 1994; 15 (12):1552-8.

Weiss W and Gorg A. High-resolution two-dimensional electrophoresis. Method Mol Biol. 2009; 13-32. doi: 10.1007/978-1-60761-157-8_2.

Xiao GG, Wang M, Li N, Loo JA and Nel AE. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem. 2003; 278(50):50781-90.

Roepstorff P. Mass spectrometry based proteomics, background, status and future needs. Protein Cell. 2012; 3(9):641-7. doi: 10.1007/s13238-012-2079-5.

Esquenazi E, Dorrestein PC and Gerwick WH. Probing marine natural product defenses with DESI-imaging mass spectrometry. P Natl Acad Sci USA. 2009;106(18):7269-70.

Klose J and Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis. 1995; 16(1):1034-59. doi:10.1002/elps.11501601175.

Poland J, Cahill MA and Sinha P. Isoelectric focusing in long immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis. 2003; 24(7-8):1271-5.

Chakravarti B, Gallagher SR and Chakravarti DN. Difference gel electrophoresis (DIGE) using CyDye DIGE fluor minimal dyes. Curr Protoc Mol Biol. 2005; 10.23. doi: 10.1002/0471142727.mb1023s69.

Unlu M, Morgan ME and Minden JS. Difference gel electrophoresis. A single gel method for detecting changes in protein extracts. Electrophoresis. 1997; 18(11):2071-7.

Liotta LA and Petricoin EF. Mass Spectrometry-based protein biomarker discovery: solving the remaining challenges to reach the promise of clinical benefit. Clin Chem. 2010; 56(10):1641-2. doi: 10.1373/clinchem.2010.146142.

Gamagedara S and Ma Y. Biomarker analysis for prostate cancer diagnosis using LC-MS and CE-MS. Bioanalysis. 2011; 3(18):2129-42. doi: 10.4155/bio.11.203.

Altelaar AM, Munoz J and Heck AJ. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet. 2013; 14(1):35-48. doi: 10.1038/nrg3356.

Bateman RJ, Munsell LY, Chen X, Holtzman DM and Yarasheski KE. Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates. J Am Soc Mass Spectr. 2007; 18(6):997-1006.

Kim YH, Fujimura Y, Hagihara T, Sasaki M, Yukihira D, Nagao T et al. In situ label-free imaging for visualizing the biotransformation of a bioactive polyphenol. Scientific reports. 2013; 3. doi:10.1038/srep02805.

Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17(10):994-9.

Mandal S, Phadtare S and Sastry M. Interfacing biology with nanoparticles. Curr Appl Phys. 2005;5(2):118-27.doi:10.1016/j.cap.2004.06.006.

Wiese S, Reidegeld KA, Meyer HE and Warscheid B. Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research. Proteomics. 2007; 7(3):340-50.

Choe L, D'Ascenzo M, Relkin NR, Pappin D, Ross P, Williamson B et al. 8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease. Proteomics. 2007; 7(20):3651-60.

Mann M. Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Bio. 2006; 7(12):952-8.

Olsen JV and Mann M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol Cell Proteomics. 2013; 12(12):3444-52. doi: 10.1074/mcp.O113.034181.

Abdallah C, Dumas-Gaudot E, Renaut J and Sergeant K. Gel-based and gel-free quantitative proteomics approaches at a glance. International journal of plant genomics. 2012; (2012) 1-17. doi.org/10.1155/2012/494572.

Liu H, Sadygov RG and Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004; 76(14):4193-201.

Zhang G, Ueberheide BM, Waldemarson S, Myung SM, Molloy K, Eriksson J et al. Protein quantitation using mass spectrometry. Method Mol Biol. 2010; 211-22. doi: 10.1007/978-1-60761-842-3_13.

Filiou MD, Martins-de-Souza D, Guest PC, Bahn S and Turck CW. To label or not to label: applications of quantitative proteomics in neuroscience research. Proteomics. 2012; 12(4-5):736-47. doi: 10.1002/pmic.201100350.

Kohler K and Seitz H. Validation processes of protein biomarkers in serum—a cross platform comparison. Sensors. 2012; 12(9):12710-28.

Hsieh SC, Chang CC, Lu CC, Wei CF, Lin CS, Lai HC et al. Rapid identification of Mycobacterium tuberculosis infection by a new array format-based surface plasmon resonance method. Nanoscale Res Lett. 2012; 7(1):1-6. doi: 10.1186/1556-276X-7-180.

Downloads

Published

31.12.2014

Issue

Section

Articles

How to Cite

Preterm intraamniotic infection and inflammation: Search for protein biomarkers via proteomics approach. (2014). Journal of Biochemistry, Microbiology and Biotechnology, 2(2), 47-56. https://doi.org/10.54987/jobimb.v2i2.148